COMP <GO>
SMG vs NEM // FORWARD P/E MULTIPLE
Scotts Miracle-Gro Company (The) (NYSE) VS. Newmont Corporation (NYSE) • 15-METRIC TALLY: SMG 2
— NEM 12
▲ FORWARD P/E MULTIPLE LEADER: NEM
LAST: $62.24 (+0.60%) • MKT CAP: $3.60B
forward-pe
23.1x
LAST: $106.61 (-4.64%) • MKT CAP: $116.18B
forward-pe
13.8x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SMG VS. NEM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SMG | NEM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 30.60% | 41.00% | -10.40 | NEM | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.30% | 21.80% | -5.50 | NEM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.2x | 11.9x | +1.30 | NEM | /valuation <GO> |
| Free Cash Flow Yield | 7.60% | 8.02% | -0.42 | NEM | /fcf-yield <GO> |
| Operating Margin | 10.50% | 38.10% | -27.60 | NEM | /operating-margins <GO> |
| Net Profit Margin | 4.30% | 31.30% | -27.00 | NEM | /net-margins <GO> |
| Revenue Growth (YoY) | -3.90% | 21.30% | -25.20 | NEM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.28% | 0.95% | +3.33 | SMG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.32 | 4.16 | -1.84 | NEM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | NEM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 7.00% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 75.5 | 36.1 | +39.37 | SMG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.03 | 1.04 | -0.01 | NEM | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 23.1x | 13.8x | +9.30 | NEM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.60B | $116.18B | -$112.58B | NEM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SMG REV | NEM REV | SMG GROSS % | NEM GROSS % | SMG FCF | NEM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.41B | $22.67B | 30.6% | 44.0% | $273.9M | $9.31B |
| FY 2024 | $3.55B | $18.68B | 23.9% | 44.0% | $583.5M | $5.52B |
| FY 2023 | $3.55B | $11.81B | 44.0% | 44.0% | $371.2M | $2.23B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SMG // BETA 1.03
NEM // BETA 1.04